Contradicting experts, Trump promises 100 million doses of COVID-19 vaccine by the end of the year

Contradicting Experts, Trump Promises 100 Million Doses Of COVID-19 Vaccine By The End Of The Year

Washington – President Donald Trump on Wednesday contradicted experts from the governmental Centers for Disease Control and Prevention (CDC) and promised that he will be able to distribute 100 million doses of the COVID-19 vaccine by the end of year.

“We will be able to distribute 100 million doses of vaccines by the end of 2020, and then a very large number afterward,” Trump said at a press conference at the White House.

Trump’s statements contradict the CDC director himself, Robert Redfield, who today at a hearing in the US Senate explained that the vaccine will be available between November and December but will be distributed in a limited way to the most at-risk groups. to die from the virus.

RELATED

Additionally, Redfield indicated that Americans will be able to access the vaccine “probably looking at the third, late second quarter, third quarter of 2021.”

Asked about it, Trump considered that Redfield was wrong, stated that he was “surprised” by his statements and explained that he called him by phone to explain that he had made a “mistake.”

“I think he made a mistake when he (Redfield) said that, it’s just wrong information. I called him and he didn’t say that and I think maybe he got the message mixed up, maybe he said it incorrectly. No, we are ready to move forward immediately, ”said the president.

Trump said Tuesday that the vaccine could be ready “in four weeks” and today insisted that it be announced “in October”, “perhaps in mid-October”, “a little after October” or “in November, but no more. late from that ”.

To be distributed to the population, any vaccine must be endorsed by the US Food and Drug Administration (FDA), the government agency that is responsible for approving the use of new drugs, vaccines and other products. related to public health.

Pharmaceutical companies Pfizer, Moderna and AstraZeneca are conducting vaccine studies in the US that are already in phase 3, but have not yet submitted their product to the FDA for review. Once the FDA approves the vaccine, authorities will be able to distribute the first doses in just 24 hours, announced Wednesday Paul Ostrowski, who oversees the logistics of Operation Warp Speed, launched by the government to accelerate efforts to contain the pandemic. The US is the country in the world most affected by the pandemic, with 6.6 million cases detected and more than 196,000 deaths, according to independent data from Johns Hopkins University.

READ MORE NEWS

YOU MAY ALSO LIKE

Leave a Reply

Your email address will not be published. Required fields are marked *

29 + = 39